
Natglycan Inc (AKA: Natglycan LLC) Profile last edited on: 3/2/2021
CAGE: 7KV47
UEI: NMMMHXNPL8U5
Business Identifier: Novel approach to released N-glycans, O-glycans and GSLglycans directly from natural sources using inexpensive, simple chemical methods Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 04
County: DeKalb
Congr. District: 04
County: DeKalb
Public Profile
Co-founded by two Emory university professors- in Atlanta, GA - NatGlycan, LLC is a biotech corporation focused on large-scale natural glycans. Principals of the firm have developed proprietary glycan extraction techniques that enable llarge scale preparation of natural glycans. The firm's proprietary process is based on a controlled oxidation using sodium hypochlorite (household bleach). Principals describe most natural glycans occuring as glycoconjugates - glycans are attached to other biomolecules such as proteins or lipids. Due to the high oxidation state of glycans, they are much more resistant to oxidative degradation than proteins and lipids including their linkages with glycans. As a result N-, O-glycans from glycoproteins and glycans from glycosphingolipids are quickly released by bleach with different reducing end structures and can be easily derivatized with fluorescent tags. Released N-, O- and GSL-glycans possess different reducing end structures and can be further derivatized for HPLC seperation
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 1 | NIH | $314,971 | |
Project Title: A Human Salivary Glycome Discovery Platform for Interrogating Glycan Function in Oral Innate Immunity | ||||
2021 | 2 | NIH | $2,170,937 | |
Project Title: Natural Glycans for Functional Glycomics | ||||
2020 | 2 | NIH | $289,301 | |
Project Title: A Natural Glycan Array of the Human Milk Glycome | ||||
2017 | 1 | NIH | $285,524 | |
Project Title: Large Scale Preparation of Natural Glycans |
Key People / Management
David Fletcher Smith -- CEO
Janice Kimpel -- Chief Business Officer
Xuezheng Song
Janice Kimpel -- Chief Business Officer
Xuezheng Song
Company News
There are no news available.